Sage Therapeutics Statistics
Total Valuation
First Tellurium has a market cap or net worth of 10.02 million. The enterprise value is 10.11 million.
| Market Cap | 10.02M |
| Enterprise Value | 10.11M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 115.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -19.99% |
| Shares Change (QoQ) | +16.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 103.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 571.99 |
| P/TBV Ratio | 350.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.97 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.76 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 28.93.
| Current Ratio | 0.46 |
| Quick Ratio | 0.46 |
| Debt / Equity | 28.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.44 |
| Interest Coverage | -16.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -62.37% |
| Return on Invested Capital (ROIC) | -204.66% |
| Return on Capital Employed (ROCE) | -5,850.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.62% in the last 52 weeks. The beta is -0.05, so First Tellurium's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -1.62% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 52.21 |
| Average Volume (20 Days) | 58,916 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.02M |
| Pretax Income | -1.27M |
| Net Income | -1.27M |
| EBITDA | -957,900 |
| EBIT | -1.02M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 406,352 in cash and 506,750 in debt, giving a net cash position of -100,398.
| Cash & Cash Equivalents | 406,352 |
| Total Debt | 506,750 |
| Net Cash | -100,398 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17,517 |
| Book Value Per Share | 0.00 |
| Working Capital | -688,487 |
Cash Flow
In the last 12 months, operating cash flow was -1.10 million and capital expenditures -58,213, giving a free cash flow of -1.15 million.
| Operating Cash Flow | -1.10M |
| Capital Expenditures | -58,213 |
| Free Cash Flow | -1.15M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
First Tellurium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 19.99% |
| Shareholder Yield | n/a |
| Earnings Yield | -12.65% |
| FCF Yield | -11.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 28, 2018. It was a reverse split with a ratio of 0.2.
| Last Split Date | Feb 28, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |